 CAMBRIDGE, Mass., Feb. 04, 2021 GLOBE NEWSWIRE -- Genocea Biosciences, Inc. NASDAQ: GNCA, a biopharmaceutical company developing next-generation neoantigen immunotherapies, will host its fourth quarter 2020 financial results and corporate update conference call and live audio webcast on Thursday, February 11th at 8:30 a.m. ET. 